Hakutulokset - Vladimir Tolmachev

Tarkenna hakua
  1. 1
    Affibody Molecules as Targeting Vectors for PET Imaging

    Affibody Molecules as Targeting Vectors for PET Imaging Tekijä Vladimir Tolmachev, Anna Orlova

    Julkaistu 2020
    Hae kokoteksti Hae kokoteksti
    Revisão
    Lisää suosikkeihin
    Tallennettuna:
  2. 2
    Methods for Radiolabelling of Monoclonal Antibodies

    Methods for Radiolabelling of Monoclonal Antibodies Tekijä Vladimir Tolmachev, Anna Orlova, Karl Andersson

    Julkaistu 2013
    Hae kokoteksti
    Artigo
    Lisää suosikkeihin
    Tallennettuna:
  3. 3
    On the Selection of a Tracer for PET Imaging of HER2-Expressing Tumors: Direct Comparison of a <sup>124</sup>I-Labeled Affibody Molecule and Trastuzumab in a Murine Xenograft Model

    On the Selection of a Tracer for PET Imaging of HER2-Expressing Tumors: Direct Comparison of a <sup>124</sup>I-Labeled Affibody Molecule and Trastuzumab in a Murine Xenograft Model Tekijä Anna Orlova, Helena Wållberg, Sharon Stone‐Elander, Vladimir Tolmachev

    Julkaistu 2009
    Hae kokoteksti Hae kokoteksti
    Artigo
    Lisää suosikkeihin
    Tallennettuna:
  4. 4
    Imaging using radiolabelled targeted proteins: radioimmunodetection and beyond

    Imaging using radiolabelled targeted proteins: radioimmunodetection and beyond Tekijä Javad Garousi, Anna Orlova, Fredrik Y. Frejd, Vladimir Tolmachev

    Julkaistu 2020
    Hae kokoteksti Hae kokoteksti
    Revisão
    Lisää suosikkeihin
    Tallennettuna:
  5. 5
    Affibody molecules: Engineered proteins for therapeutic, diagnostic and biotechnological applications

    Affibody molecules: Engineered proteins for therapeutic, diagnostic and biotechnological applications Tekijä John Löfblom, Joachim Feldwisch, Vladimir Tolmachev, J. Carlsson, S. Ståhl, Fredrik Y. Frejd

    Julkaistu 2010
    Hae kokoteksti Hae kokoteksti
    Revisão
    Lisää suosikkeihin
    Tallennettuna:
  6. 6
    Tumor Targeting Using Affibody Molecules: Interplay of Affinity, Target Expression Level, and Binding Site Composition

    Tumor Targeting Using Affibody Molecules: Interplay of Affinity, Target Expression Level, and Binding Site Composition Tekijä Vladimir Tolmachev, Thuy Tran, Daniel Rosik, Anna Sjöberg, Lars Abrahmsén, Anna Orlova

    Julkaistu 2012
    Hae kokoteksti Hae kokoteksti
    Artigo
    Lisää suosikkeihin
    Tallennettuna:
  7. 7
    Extending Half-life by Indirect Targeting of the Neonatal Fc Receptor (FcRn) Using a Minimal Albumin Binding Domain

    Extending Half-life by Indirect Targeting of the Neonatal Fc Receptor (FcRn) Using a Minimal Albumin Binding Domain Tekijä Jan Terje Andersen, Rikard Pehrson, Vladimir Tolmachev, Muluneh Bekele Daba, Lars Abrahmsén, Caroline Ekblad

    Julkaistu 2010
    Hae kokoteksti Hae kokoteksti
    Artigo
    Lisää suosikkeihin
    Tallennettuna:
  8. 8
    Affibody-mediated PET imaging of HER3 expression in malignant tumours

    Affibody-mediated PET imaging of HER3 expression in malignant tumours Tekijä Maria� Rosestedt, Karl Andersson, Bogdan Mitran, Vladimir Tolmachev, John Löfblom, Anna Orlova, Stefan Ståhl

    Julkaistu 2015
    Hae kokoteksti Hae kokoteksti
    Artigo
    Lisää suosikkeihin
    Tallennettuna:
  9. 9
    Selection and characterization of HER2/neu-binding affibody ligands

    Selection and characterization of HER2/neu-binding affibody ligands Tekijä Maria Wikman, A.-C. Steffen, Elin Gunneriusson, Vladimir Tolmachev, Gregory P. Adams, J. Carlsson, S. Ståhl

    Julkaistu 2004
    Hae kokoteksti Hae kokoteksti
    Artigo
    Lisää suosikkeihin
    Tallennettuna:
  10. 10
    Feasibility of Affibody Molecule-Based PNA-Mediated Radionuclide Pretargeting of Malignant Tumors

    Feasibility of Affibody Molecule-Based PNA-Mediated Radionuclide Pretargeting of Malignant Tumors Tekijä Hadis Honarvar, Kristina Westerlund, Mohamed Altai, Mattias Sandström, Anna Orlova, Vladimir Tolmachev, Amelie Eriksson Karlström

    Julkaistu 2015
    Hae kokoteksti
    Artigo
    Lisää suosikkeihin
    Tallennettuna:
  11. 11
    Influence of Nuclides and Chelators on Imaging Using Affibody Molecules: Comparative Evaluation of Recombinant Affibody Molecules Site-Specifically Labeled with <sup>68</sup>Ga and <sup>111</sup>In via Maleimido Derivatives of DOTA and NODAGA

    Influence of Nuclides and Chelators on Imaging Using Affibody Molecules: Comparative Evaluation of Recombinant Affibody Molecules Site-Specifically Labeled with <sup>68</sup>Ga and... Tekijä Mohamed Altai, Joanna Strand, Daniel Rosik, Ram Kumar Selvaraju, Amelie Eriksson Karlström, Anna Orlova, Vladimir Tolmachev

    Julkaistu 2013
    Hae kokoteksti
    Artigo
    Lisää suosikkeihin
    Tallennettuna:
  12. 12
    Influence of Macrocyclic Chelators on the Targeting Properties of 68Ga-Labeled Synthetic Affibody Molecules: Comparison with 111In-Labeled Counterparts

    Influence of Macrocyclic Chelators on the Targeting Properties of 68Ga-Labeled Synthetic Affibody Molecules: Comparison with 111In-Labeled Counterparts Tekijä Joanna Strand, Hadis Honarvar, Anna Perols, Anna Orlova, Ram Kumar Selvaraju, Amelie Eriksson Karlström, Vladimir Tolmachev

    Julkaistu 2013
    Hae kokoteksti Hae kokoteksti
    Artigo
    Lisää suosikkeihin
    Tallennettuna:
  13. 13
    Molecular Design and Optimization of <sup>99m</sup>Tc-Labeled Recombinant Affibody Molecules Improves Their Biodistribution and Imaging Properties

    Molecular Design and Optimization of <sup>99m</sup>Tc-Labeled Recombinant Affibody Molecules Improves Their Biodistribution and Imaging Properties Tekijä Helena Wållberg, Anna Orlova, Mohammed Altai, Seyed Jalal Hosseinimehr, Charles Widström, Jennie Malmberg, Stefan Ståhl, Vladimir Tolmachev

    Julkaistu 2011
    Hae kokoteksti Hae kokoteksti
    Artigo
    Lisää suosikkeihin
    Tallennettuna:
  14. 14
    Molecular Imaging of <i>HER2</i>-Expressing Malignant Tumors in Breast Cancer Patients Using Synthetic <sup>111</sup>In- or <sup>68</sup>Ga-Labeled Affibody Molecules

    Molecular Imaging of <i>HER2</i>-Expressing Malignant Tumors in Breast Cancer Patients Using Synthetic <sup>111</sup>In- or <sup>68</sup>Ga-Labeled Affibody Molecules Tekijä Richard P. Baum, Vikas Prasad, Dirk Müller, Christiane Schuchardt, Anna Orlova, Anders Wennborg, Vladimir Tolmachev, Joachim Feldwisch

    Julkaistu 2010
    Hae kokoteksti Hae kokoteksti
    Artigo
    Lisää suosikkeihin
    Tallennettuna:
  15. 15
    Locally Delivered CD40 Agonist Antibody Accumulates in Secondary Lymphoid Organs and Eradicates Experimental Disseminated Bladder Cancer

    Locally Delivered CD40 Agonist Antibody Accumulates in Secondary Lymphoid Organs and Eradicates Experimental Disseminated Bladder Cancer Tekijä Linda C. Sandin, Anna Orlova, Erika Gustafsson, Peter Ellmark, Vladimir Tolmachev, Thomas H. Tötterman, Sara M. Mangsbo

    Julkaistu 2013
    Hae kokoteksti Hae kokoteksti
    Artigo
    Lisää suosikkeihin
    Tallennettuna:
  16. 16
    PET imaging of epidermal growth factor receptor expression in tumours using 89Zr-labelled ZEGFR:2377 affibody molecules

    PET imaging of epidermal growth factor receptor expression in tumours using 89Zr-labelled ZEGFR:2377 affibody molecules Tekijä Javad Garousi, Karl Andersson, Bogdan Mitran, MARIE-LOUISE PICHL, Stefan Ståhl, Anna Orlova, John Löfblom, Vladimir Tolmachev

    Julkaistu 2016
    Hae kokoteksti Hae kokoteksti
    Artigo
    Lisää suosikkeihin
    Tallennettuna:
  17. 17
    Imaging of Insulinlike Growth Factor Type 1 Receptor in Prostate Cancer Xenografts Using the Affibody Molecule<sup>111</sup>In-DOTA-Z<sub>IGF1R:4551</sub>

    Imaging of Insulinlike Growth Factor Type 1 Receptor in Prostate Cancer Xenografts Using the Affibody Molecule<sup>111</sup>In-DOTA-Z<sub>IGF1R:4551</sub> Tekijä Vladimir Tolmachev, Jennie Malmberg, Camilla Hofström, Lars Abrahmsén, Thomas Bergman, Anna Sjöberg, Mattias Sandström, Torbjörn Gräslund, Anna Orlova

    Julkaistu 2011
    Hae kokoteksti Hae kokoteksti
    Artigo
    Lisää suosikkeihin
    Tallennettuna:
  18. 18
    Intra-image referencing for simplified assessment of HER2-expression in breast cancer metastases using the Affibody molecule ABY-025 with PET and SPECT

    Intra-image referencing for simplified assessment of HER2-expression in breast cancer metastases using the Affibody molecule ABY-025 with PET and SPECT Tekijä Dan Sandberg, Vladimir Tolmachev, Irina Velikyan, Helena Olofsson, Anders Wennborg, Joachim Feldwisch, Jörgen Carlsson, Henrik Lindman, Jens Sörensen

    Julkaistu 2017
    Hae kokoteksti Hae kokoteksti
    Artigo
    Lisää suosikkeihin
    Tallennettuna:
  19. 19
    HAHAHA, HEHEHE, HIHIHI, or HKHKHK: Influence of Position and Composition of Histidine Containing Tags on Biodistribution of [<sup>99m</sup>Tc(CO)<sub>3</sub>]<sup>+</sup>-Labeled Affibody Molecules

    HAHAHA, HEHEHE, HIHIHI, or HKHKHK: Influence of Position and Composition of Histidine Containing Tags on Biodistribution of [<sup>99m</sup>Tc(CO)<sub>3</sub>]<sup>+</sup>-Labeled A... Tekijä Camilla Hofström, Mohamed Altai, Hadis Honarvar, Joanna Strand, Jennie Malmberg, Seyed Jalal Hosseinimehr, Anna Orlova, Torbjörn Gräslund, Vladimir Tolmachev

    Julkaistu 2013
    Hae kokoteksti
    Artigo
    Lisää suosikkeihin
    Tallennettuna:
  20. 20
    Pharmacokinetics and red cell utilization of iron(III) hydroxide–sucrose complex in anaemic patients: a study using positron emission tomography

    Pharmacokinetics and red cell utilization of iron(III) hydroxide–sucrose complex in anaemic patients: a study using positron emission tomography Tekijä Soheir Beshara, Hans Lundqvist, Johanna Sundin, Mark Lubberink, Vladimir Tolmachev, Sven Valind, Gunnar Antoni, Bengt Långström, Bo G. Danielson

    Julkaistu 1999
    Hae kokoteksti Hae kokoteksti
    Artigo
    Lisää suosikkeihin
    Tallennettuna:

Työkalut: